PPARGC1A and lip and oral cavity carcinoma: Pharmacological inhibition of PPARGC1A combined with cisplatin disturbed the balance between mitophagy and mitochondrial biogenesis, leading to excessive mitophagy, showing a potent synergistic effect in in vitro and in vivo models of oral cancer.